Alpex Acquisition Corporation (NASDAQ: ALPXU) announced the closing of its initial public offering of 11.5 million units, including the full exercise of the underwriters' over-allotment option, generating gross proceeds of $115 million before expenses. The units began trading on the Nasdaq Global Market on June 25 under the ticker "ALPXU," with each unit consisting of one Class A ordinary share, one redeemable warrant and one right to receive one-fourth of one Class A ordinary share upon completion of an initial business combination.
Concurrently with the IPO, the company completed a private placement of 187,500 units that raised an additional $1.875 million in gross proceeds. Alpex said $115 million of the net proceeds from the public offering and private placement has been placed in trust, with an audited balance sheet to be included in a forthcoming Current Report on Form 8-K filed with the U.S. Securities and Exchange Commission.
The successful IPO, including the full exercise of the over-allotment option, indicates strong demand for Alpex's units despite a challenging environment for special purpose acquisition companies (SPACs). The SPAC market has seen a slowdown in new issuances and increased regulatory scrutiny, but Alpex's ability to raise $115 million suggests that investors remain willing to back experienced management teams seeking acquisition targets.
Alpex Acquisition Corporation is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities. The Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region. This flexibility allows Alpex to pursue opportunities across various sectors, potentially including technology, healthcare, or industrials, which may appeal to investors seeking diversified exposure.
The completion of this IPO also highlights the ongoing role of SPACs as an alternative route to public markets for private companies. With $115 million in trust, Alpex is well-positioned to pursue a target with a meaningful enterprise value. The inclusion of warrants and rights in the unit structure provides additional upside potential for investors, which may have contributed to the demand.
For more details on the announcement, visit https://ibn.fm/3xTGJ.
